KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Return on Sales (2019 - 2025)

Historic Return on Sales for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to 0.01%.

  • GoodRx Holdings' Return on Sales fell 100.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year increase of 600.0%. This contributed to the annual value of 0.02% for FY2024, which is 300.0% up from last year.
  • According to the latest figures from Q3 2025, GoodRx Holdings' Return on Sales is 0.01%, which was down 100.0% from 0.06% recorded in Q2 2025.
  • In the past 5 years, GoodRx Holdings' Return on Sales ranged from a high of 0.31% in Q2 2023 and a low of 0.22% during Q3 2022
  • Over the past 5 years, GoodRx Holdings' median Return on Sales value was 0.01% (recorded in 2025), while the average stood at 0.01%.
  • As far as peak fluctuations go, GoodRx Holdings' Return on Sales surged by 17600bps in 2021, and later crashed by -2800bps in 2024.
  • GoodRx Holdings' Return on Sales (Quarter) stood at 0.19% in 2021, then skyrocketed by 94bps to 0.01% in 2022, then crashed by -1128bps to 0.13% in 2023, then soared by 126bps to 0.03% in 2024, then plummeted by -83bps to 0.01% in 2025.
  • Its Return on Sales was 0.01% in Q3 2025, compared to 0.06% in Q2 2025 and 0.05% in Q1 2025.